Effect of informed consent on patient characteristics in a stroke thrombolysis trial
Götz Thomalla(Universität Hamburg), Christian Gerloff(Universität Hamburg), Ian Ford, Robin Lemmens(VIB-KU Leuven Center for Microbiology), Salvador Pedraza(Hospital Clínic de Barcelona), Bastian Cheng(Universität Hamburg), Vincent Thijs(Florey Institute of Neuroscience and Mental Health), Christoph Heesen(Universität Hamburg), Norbert Nighoghossian(Université Claude Bernard Lyon 1), Tae‐Hee Cho(Université Claude Bernard Lyon 1), Pascal Roy(Université Claude Bernard Lyon 1), Jens Fiehler(Universität Hamburg), Martin Ebinger(Universität Hamburg), Jochen B. Fiebach(Pathodiagnostik Berlin), Claus Z. Simonsen(Universität Hamburg), Josep Puig(Universität Hamburg), Matthias Endres(German Center for Neurodegenerative Diseases), Keith W. Muir(University of Glasgow), Florent Boutitie(Université Claude Bernard Lyon 1)
Cited by 24
Related Papers
Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2.8k
Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2k
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
|New England Journal of Medicine|2018|1.3k
Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke
|New England Journal of Medicine|2019|1k
Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke
|New England Journal of Medicine|2018|856